Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study demonstrating that its algorithmic test, Immune ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Net revenue was $9.9 million, compared to $13.5 million in the second quarter of fiscal 2025. GAAP net loss was $(3.2) million, or $(0.11) per diluted share, compared to GAAP net loss of $(1.0) ...
LAS VEGAS, Jan 6 (Reuters) - Amazon's (AMZN.O), opens new tab cloud unit has partnered with German automotive hardware supplier Aumovio (AMV0n.DE), opens new tab to support the commercial rollout of ...
LAS VEGAS, Jan ‌6 (Reuters) - Amazon's cloud unit has partnered ‌with German automotive hardware supplier Aumovio to support the commercial rollout of self-driving vehicles, starting with Aurora's ...
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, ...
A new technical paper titled “LLM-based Behaviour Driven Development for Hardware Design” was published by researchers at University of Bremen/DFKI. “Test and verification are essential activities in ...
AI is a strategic enabler throughout the entire development and test process. dSPACE has been exploring how the latest developments in generative and agentic AI technologies can support ...
Northrop Grumman test-fired a solid rocket motor called SMASH!22 Dec. 4 as part of its SMART Demo development program. Credit: Northrop Grumman WASHINGTON — Northrop Grumman tested a solid rocket ...
Taiwan's dedicated chip backend house Lingsen Precision Industries is stepping up capacity expansion and price adjustments as AI-fueled demand for memory chip testing accelerates. President Tse-sung ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...